Monashee Investment Management LLC Alnylam Pharmaceuticals, Inc. Transaction History

Monashee Investment Management LLC

  • $774 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 01, 2022
BUY
$138.54 - $232.0 $415,620 - $696,000
3,000 New
3,000 $600,000
Q3 2019

Nov 12, 2019
SELL
$70.9 - $87.82 $4.25 Million - $5.27 Million
-60,000 Closed
0 $0
Q2 2019

Aug 07, 2019
BUY
$65.86 - $92.79 $3.72 Million - $5.24 Million
56,500 Added 1614.29%
60,000 $4.35 Million
Q1 2019

May 13, 2019
BUY
$72.76 - $93.45 $254,660 - $327,075
3,500 New
3,500 $327,000

Others Institutions Holding ALNY

# of Institutions
642
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.21M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $30.1B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Monashee Investment Management LLC Portfolio

Follow Monashee Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monashee Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email